ISPE’s virtual events will center around the sustainable implementation of and shared responsibility for quality risk management, while providing a space for regulators and industry leaders to share lessons and maintain transparency.
The International Society for Pharmaceutical Engineering (ISPE) announced on May 6, 2021 that it will virtually host the 2021 ISPE Global Pharmaceutical Regulatory Summit on June 16, 2021 and the 2021 ISPE Asia Pacific Pharmaceutical Manufacturing Conference from June 17–18, 2021.
According to a company press release, the virtual events will center around the sustainable implementation of and shared responsibility for quality risk management, while providing a space for regulators and industry leaders to share lessons and maintain transparency.
“The global pandemic has impacted all operations, no matter the size or manufacturing capabilities. As companies in the Asia Pacific region and around the world adapt to changing regulatory processes, contend with remote and limited inspections, and manage increasing demands on CMOs, effective quality risk assessment and risk mitigation have become exponentially more significant,” said Frances Zipp, president and CEO, Lachman Consultant Services, and conference co-chair, in the press release. “These events require a visionary approach in assessing the challenges facing pharmaceutical operations on a global basis, specifically for those that are critical to the supply of essential medicines, such as in the Asia Pacific region, amid unpredictable times.”
“Collaboration and communication are a crucial element in mitigating the impact of COVID-19 on pharmaceutical operations,” added Carmelo Rosa, director, Division of Drug Quality I, FDA/CDER/OC/OMQ, and conference co-chair in the press release. “During both events, attendees will have the chance to ask questions to industry experts and regulators and learn about the strategies and insights other companies are using to make their operations more agile, compliant, and resilient to disruption.”
Summit speakers and panelists include:
Conference speakers and panelists include:
Source: ISPE
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.